SGH
LH icon

Sivik Global Healthcare’s Labcorp LH Stock Holding History

Sivik Global Healthcare’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,000
Closed -$2.87M – 53
2025
Q3 		$2.87M Buy
+10,000
New +$2.68M 0.84% 40
2024
Q1 		– Sell
-15,000
Closed -$3.41M – 51
2023
Q4 		$3.41M Buy
+15,000
New +$3.15M 1.42% 35
2022
Q2 		– Sell
-23,280
Closed -$5.27M – 47
2022
Q1 		$5.27M Sell
23,280
-2,910
-11% -$684K 2.18% 22
2021
Q4 		$7.07M Sell
26,190
-2,910
-10% -$720K 3.03% 12
2021
Q3 		$7.04M Hold
29,100
– – 1.68% 24
2021
Q2 		$6.9M Hold
29,100
– – 1.35% 23
2021
Q1 		$6.38M Sell
29,100
-8,730
-23% -$1.75M 2.33% 24
2020
Q4 		$6.62M Sell
37,830
-8,730
-19% -$1.51M 2.7% 21
2020
Q3 		$7.53M Sell
46,560
-23,280
-33% -$3.69M 3.24% 10
2020
Q2 		$9.97M Buy
+69,840
New +$9.66M 3.3% 5
2020
Q1 		– Sell
-29,100
Closed -$4.23M – 53
2019
Q4 		$4.23M Sell
29,100
-5,820
-17% -$840K 1.57% 34
2019
Q3 		$5.04M Sell
34,920
-5,820
-14% -$849K 2.54% 22
2019
Q2 		$6.05M Buy
40,740
+11,640
+40% +$1.62M 1.46% 13
2019
Q1 		$3.83M Buy
+29,100
New +$3.58M 1.41% 35
2018
Q4 		– Sell
-17,460
Closed -$2.6M – 57
2018
Q3 		$2.6M Buy
+17,460
New +$2.66M 0.93% 45
2018
Q1 		– Sell
-23,280
Closed -$3.19M – 64
2017
Q4 		$3.19M Buy
23,280
+7,100
+44% +$938K 1.18% 40
2017
Q3 		$2.1M Buy
+16,180
New +$2.16M 0.71% 53
2016
Q3 		– Sell
-34,920
Closed -$3.91M – 57
2016
Q2 		$3.91M Buy
+34,920
New +$3.76M 1.94% 22
2014
Q4 		– Sell
-57,502
Closed -$5.03M – 70
2014
Q3 		$5.03M Buy
57,502
+10,942
+24% +$989K 2.28% 10
2014
Q2 		$4.1M Buy
46,560
+11,640
+33% +$1.01M 2.07% 20
2014
Q1 		$2.95M Buy
+34,920
New +$2.78M 1.84% 22

Other funds holding LH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sivik Global Healthcare's LH Position: Q4 2025 in Review

Sivik Global Healthcare sold out of Labcorp (LH) in Q4 2025, closing a stake of 10,000 shares — an estimated $2.87M sold.

Sivik Global Healthcare first reported a position in LH in Q1 2014 and held it in 21 quarters. The position peaked at $9.97M in Q2 2020. 1,024 funds tracked by Wall St. Rank hold LH as of Q4 2025.

  • Sivik Global Healthcare reported no remaining Labcorp position as of Q4 2025 after selling out during the quarter.
  • Sivik Global Healthcare sold 10,000 Labcorp shares in Q4 2025, an estimated $2.87M.
  • Sivik Global Healthcare first reported a position in Labcorp in Q1 2014 and held it in 21 quarters.
  • Sivik Global Healthcare's Labcorp position peaked at $9.97M in Q2 2020.
  • 1,024 funds tracked by Wall St. Rank held Labcorp as of Q4 2025.

Based on Sivik Global Healthcare's 13F filing for Q4 2025, filed 21 Jan 2026.